US2002119525A1PendingUtilityA1
TAB1 protein and DNA coding therefore
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Apr 24, 1996Filed: Apr 17, 2002Published: Aug 29, 2002
Est. expiryApr 24, 2016(expired)· nominal 20-yr term from priority
C07K 14/4702
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
TAB1 protein having activity which activates factor TAK1 in the TGF-β signaling pathway, and having the amino acid sequence shown in FIG. 1.
Claims
exact text as granted — not AI-modified1 . TAB1 protein having the amino acid sequence shown in SEQ ID NO: 1.
2 . A protein having an amino acid sequence modified by a substitution, deletion and/or addition of one or more amino acids in the amino acid sequence shown in SEQ ID NO: 1, and having a biological property of TAB1 protein.
3 . A protein encoded by DNA which can hybridize with DNA having the nucleotide sequence shown in SEQ ID NO: 1 under hybridization conditions of 60° C., 0.1×SSC, 0.1% sodium dodecyl sulfate, and which has a biological property of TAB1 protein.
4 . A protein having an amino acid sequence consisting of the amino acids from amino acid positions 21 to 579 of the amino acid sequence shown in SEQ ID NO: 1.
5 . A polypeptide having the amino acid sequence consisting of the 68 amino acids from amino acid positions 437 to 504 of the amino acid sequence shown in SEQ ID NO: 1.
6 . A protein according to claimed in claim 2 , wherein the 52nd amino acid in the amino acid sequence shown in SEQ ID NO: 1 is arginine.
7 . A fusion protein comprising a protein or polypeptide according to any of claims 1 to 6 .
8 . A method for producing a protein or polypeptide according to any of claims 1 to 7 , comprising the steps of:
culturing a host transformed by an expression vector comprising DNA encoding said protein or polypeptide, and
recovering said protein or polypeptide from the culture.
9 . A method according to claim 8 , wherein said host is a mammalian cell or yeast cell.
10 . A method for inducing mammalian cells to produce a protein or polypeptide according to any of claims 1 to 7 , comprising the step of introducing DNA encoding said protein or polypeptide into mammalian cells.
11 . DNA encoding a protein or polypeptide according to any of claims 1 to 7 .
12 . An expression vector comprising DNA according to claim 11 .
13 . A host transformed by an expression vector according to claim 12 .
14 . A host according to claim 13 , wherein said host is a mammalian cell or yeast cell.
15 . A method for screening TGF-β signaling pathway inhibitors, characterized by (A) contacting a sample containing TGF-β signaling pathway inhibitors with or introducing it into cells expressing a TAB1 protein or polypeptide according to any of claims 1 to 6 and TAK1 protein, and (B) measuring the kinase activity of the TAK1 protein.Join the waitlist — get patent alerts
Track US2002119525A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.